Back to Search
DWIGHT LUNDELL, MD
MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician
NPI: 1760672190Individual
Specialties, Licenses & Credentials
Thoracic Surgery (Cardiothoracic Vascular Surgery) PhysicianPrimary
Thoracic Surgery (Cardiothoracic Vascular Surgery)
Code: 208G00000X
6960(AZ)
Research & Publications (20)
3,4-Diamino-1,2,5-thiadiazole as potent and selective CXCR2 antagonists.
PMID 19200721·Bioorg Med Chem Lett·2009
4-observational
Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region.
PMID 19525110·Bioorg Med Chem Lett·2009
7-preclinical
Fluoroalkyl alpha side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2-CXCR1 dual antagonists.
PMID 19196511·Bioorg Med Chem Lett·2009
4-observational
ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha.
PMID 19158376·Mol Biol Cell·2009
7-preclinical
Discovery of novel spirocyclopropyl hydroxamate and carboxylate compounds as TACE inhibitors.
PMID 19054672·Bioorg Med Chem Lett·2009
8-other
Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans.
PMID 18403723·Am J Respir Crit Care Med·2008
8-other
Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.
PMID 18835710·Bioorg Med Chem Lett·2008
7-preclinical
Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors: Part I--discovery of two binding modes.
PMID 18247549·J Med Chem·2008
8-other
Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists.
PMID 18242983·Bioorg Med Chem Lett·2008
7-preclinical
Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists.
PMID 17906679·Br J Pharmacol·2008
6-review
Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8.
PMID 17197447·J Biol Chem·2007
7-preclinical
Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
PMID 17496166·J Pharmacol Exp Ther·2007
7-preclinical
C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists.
PMID 17459706·Bioorg Med Chem Lett·2007
7-preclinical
Cannabinoid CB(2)-selective inverse agonist protects against antigen-induced bone loss.
PMID 18075852·Immunopharmacol Immunotoxicol·2007
7-preclinical
Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist.
PMID 17181143·J Med Chem·2006
7-preclinical
Characterization of peripheral human cannabinoid receptor (hCB2) expression and pharmacology using a novel radioligand, [35S]Sch225336.
PMID 16754676·J Biol Chem·2006
7-preclinical
A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo.
PMID 16258021·J Pharmacol Exp Ther·2006
7-preclinical
The pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP.
PMID 15796906·Biochem Biophys Res Commun·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 770 NORTH MONTEREY, SUITE F
GILBERT, AZ 85233 - Phone
- (602) 288-8699
Quick Facts
- NPI
- 1760672190
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile